Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Respiratory diagnostic is the process, performed by the healthcare professionals or care providers to diagnose or treat patient’s respiratory problems. This diagnostic can be performed by using different tests such as pulmonary function tests, chest x-rays, lung perfusion scans and other film studies, six-minute walk test, blood tests, ECG (EKG), echocardiogram and many others. Smoking, air pollution, and arrival of infectious viruses are leading causes of the respiratory and lung diseases. Thus to reduce the prevalence rate of various respiratory and lung diseases respiratory diagnostic products and techniques are widely used across the globe.
The North America respiratory diagnostic market has been seen tremendous growth from the past few years. The major growth factors such as growing prevalence and cases of respiratory diseases such as COPD, asthma, lung cancer, and many other respiratory infectious diseases, growing technological advancements in respiratory diagnostics devices, surge in the adoption of various preventive measures to reduce air pollution that may cause respiratory diseases, increasing concerns regarding novel COVID-19 pandemic, and continuing technological advancements in the field of advanced diagnostic imaging technique are accredited to the growth of the market in the NA region.
The study analyses North America respiratory diagnostics market based on product & service, test type, disease, end user and geography.
By product & service, instrument and devices segment is witnessing fastest growth. A growing requirement for most accurate, less intrusive and less stressful diagnostic test process form patients, increasing demand for user-friendly respiratory diagnosis devices by clinicians as well as patients, and growing production and introduction of lung function testing devices or pulmonary function testing instruments are major factors that anticipated to propel the growth of this segment in the forecast period.
By test type, imaging test segment held the largest market share in 2020 and is likely to continue its position in the coming years. A surge in the adoption of analytics and artificial intelligence in diagnostic imaging, growing demand for comfortable and painless testing techniques by the people, and continuous use of chest X-ray imaging tests because of its simple operation, popularity, quick results and cost effectiveness are some of the factors that attributed to the growth of imaging test segment.
By disease, asthma segment is expected to witness fast growth at a highest growth rate during the projection period. The factors such as an increasing demand to diagnose and treat asthma in its early stage, rising focus on to reduce the social and economic burden of the asthma disease, and rising partnership, collaboration and innovation by major market players to provides effective and advanced asthma diagnostic products are expected to contribute to the growth of the this segment.
By end user, hospital/clinical laboratories segment dominated the market in 2020 and is likely to maintain its dominance during the forecast period. Increasing number of mergers and acquisitions of hospitals and hospital systems, surge in the adoption of advanced respiratory diagnostic products in the hospitals and laboratories, a surge in the demand for early diagnosis and intervention, and rising focus on the timely and accurate laboratory results to improve quality of the patient care are some of the key driving factors behind the growth of this segment.
Country wise, the study is comprised of the key countries such as the US, Canada and Mexico. The US held the largest market share of North America respiratory diagnostic market and is likely to dominate the market over the estimated time frame. Factors such as well-established healthcare industry, growing awareness about various types of respiratory diseases, growing technological advancements in the existing respiratory diagnosis systems, increasing incidence of respiratory diseases owing to the air pollution, and vast availability of advanced and innovative respiratory diagnosis devices and instruments are accredited to the growth of the market.
The major key players of market includes Abbott Laboratories, Alere Inc, Becton, Dickinson & Company, Biomérieux, Bio-Rad Laboratories, Inc, Cosmed, Philips Healthcare, Sdi Diagnostics, Seegene Inc, Thermo Fisher Scientific Inc, ResMed, Fischer & Paykel, MGC Diagnostics Corporation and Subsidiaries, and CAREstream Medical, Ltd among others.
The study analyses North America respiratory diagnostics market based on product & service, test type, disease, end user, and geography. Respiratory diagnostics market by product & service is segmented into instruments & devices, assays & reagents, and services & software. The instruments & devices segment is likely to dominate the market over the forecast period. Increased adoption of advanced instruments & devices for the diagnosis of respiratory diseases is attributed to the market growth. By test type, the market is segmented into imaging tests, mechanical tests, molecular diagnostic tests, and traditional diagnostic tests. Imaging test is witnessing fastest growth owing to the rising adoption of imaging based machines such as CT scan and x-ray. Based on disease, market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The chronic obstructive pulmonary disease segment is likely to register fastest growth in years to come owing to the growing prevalence rate across the globe. And by end user market is categorized into hospital/clinical laboratories, physician offices, reference laboratories, and other end users.Country wise, the study is comprised of the United States, Canada and Mexico.
Why to buy this report:
